EMTRICITABINE
It is a nucleoside reverse transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection in adults and children.HIV infecction
Oral; 3mg per kg in paeds group and 200mg once a day for adult.
Hypersensitivity.
Paediatric: May be used. Pregnancy: Category B. Lactation: Not to use during breast feeding. Elderly: Use with caution.
diarrhea, headache, nausea, rash, skin hyperpigmentation, Lactic acidosis, severe hepatomegaly with steatosis, Severe acute exacerbations of Hepatitis B, Immune reconstitution syndrome.
Data not sufficient.